4.7 Article

Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 27, 期 13, 页码 2741-2752

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2019.04.031

关键词

Homology modeling; Immune modulation; Molecular docking; Nucleotide pyrophosphatase; Sulfonate

资金

  1. University of Sharjah (Drug Design & Discovery Research Group Operational Fund), United Arab Emirates
  2. Boehringer-Ingelheim pharmaceutical company, United Arab Emirates
  3. Organization for the Prohibition of Chemical Weapons (OPCW), The Hague, The Netherlands and Higher Education Commission of Pakistan [20-3733/NRPU/R D/14/520]
  4. Canadian Institutes of Health Research [PJT - 156205]
  5. Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05867]
  6. Chercheur National Scholarship award from the Fonds de recherche du Quebec-Sante (FRQS)

向作者/读者索取更多资源

A new series of sulfonate derivatives 1a-zk were synthesized and evaluated as inhibitors of nucleotide pyrophosphatases. Most of the compounds exhibited good to moderate inhibition towards NPP1, NPP2, and NPP3 isozymes. Compound 1m was a potent and selective inhibitor of NPP1 with an IC50 value of 0.387 +/- 0.007 mu M. However, the most potent inhibitor of NPP3 was found as 1x with an IC50 value of 0.214 +/- 0.012 mu M. In addition, compound 1e was the most active inhibitor of NPP2 with an IC50 value of 0.659 +/- 0.007 mu M. Docking studies of the most potent compounds were carried out, and the computational results supported the in vitro results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据